<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="130988">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01733277</url>
  </required_header>
  <id_info>
    <org_study_id>A122-MER12H</org_study_id>
    <nct_id>NCT01733277</nct_id>
  </id_info>
  <brief_title>Osteoarthritis Structural Changes Assessed by Magnetic Resonance Imaging (MRI) and Neuropathic Pain in Knee Osteoarthritis</brief_title>
  <official_title>A Cross-sectional Study to Explore the Osteoarthritis Structural Changes Assessed by MRI That Are Biomarkers of Neuropathic Pain in Knee Osteoarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ArthroLab Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ArthroLab Inc.</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to identify osteoarthritis (OA) structural changes,
      as assessed by MRI, that best correlate with the presence of neuropathic pain (NP) using the
      PainDETECT questionnaire (PainDETECT ≥ 13) on a population of patients with OA of the knee
      experiencing moderate to severe pain (VAS ≥ 40 mm).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>To correlate the level of neuropathic pain with the severity of OA structural changes (cartilage volume and defects, bone marrow lesions, meniscal tears and extrusion, synovitis).</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>To assess the correlation between the presence of neuropathic pain and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) scores (total, pain, function, stiffness).</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>To assess the correlation between the presence of NP and biological markers of inflammation</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neuropathic Pain</condition>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Presence of neuropathic pain</arm_group_label>
    <description>Presence of neuropathic pain using the PainDETECT questionnaire (PainDETECT ≥ 13)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Absence of neuropathic pain</arm_group_label>
    <description>Absence of neuropathic pain using the PainDETECT questionnaire (PainDETECT &lt; 13)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>Presence of neuropathic pain</arm_group_label>
    <arm_group_label>Absence of neuropathic pain</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Presence or absence of neuropathic pain on a population of patients with OA of the knee
        experiencing moderate to severe pain (VAS ≥ 40 mm)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Individuals of either sex, aged 40 years and more;

          -  Followed in an ambulatory clinic;

          -  Presenting with primary OA of the knee according to American College of Rheumatology
             (ACR) criteria;

          -  With an OA of radiological stages 2 and 3 according to Kellgren-Lawrence;

          -  Knee pain for at least 1 month out of the 3 months preceding the study;

          -  Visual Analog Scale (VAS) of pain while walking on a flat surface ≥ 40 mm;

          -  Agrees to sign the Informed Consent Form;

          -  Not taking part in another clinical trial;

          -  Agrees to respect the protocol.

        Exclusion Criteria:

          -  Other bone and articular diseases (antecedents and/or current signs);

          -  Presenting with isolated knee lateral compartment OA defined by joint space loss in
             the lateral compartment only;

          -  Knee surgery on the study knee;

          -  Comorbidities that restrict knee function;

          -  Had received any investigational drug within 30 days or 5 half lives (whichever is
             greater) prior to entering the study;

          -  Unable to give informed consent;

          -  Counter-indication to an MRI examination;

          -  Baseline Visit cartilage volume cannot be calculated from the MRI due to advanced OA
             or any other technical reason;

          -  Abnormal findings and or any other condition, which, in the Investigator's judgment
             might increase the risk to the subject or decrease the chance of obtaining
             satisfactory data through MRI to achieve the objectives of the study.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Pierre Raynauld, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Pierre Pelletier, MD</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>26666</phone_ext>
    <email>dr@jppelletier.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrice Paiement, MSc</last_name>
    <phone>514-890-8000</phone>
    <phone_ext>28943</phone_ext>
    <email>ppaiement@arthrolab.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Rhumatologie de Montréal</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H2L-1S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Pierre Pelletier, MD</last_name>
      <phone>514-890-8000</phone>
      <phone_ext>26666</phone_ext>
      <email>dr@jppelletier.ca</email>
    </contact>
    <investigator>
      <last_name>Jean-Pierre Raynauld, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Rhumatologie St. Louis</name>
      <address>
        <city>Quebec</city>
        <zip>G1W 4R4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>André Beaulieu, MD</last_name>
      <phone>418-659-5757</phone>
    </contact>
    <investigator>
      <last_name>André Beaulieu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 30, 2012</lastchanged_date>
  <firstreceived_date>November 16, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Neuropathic pain</keyword>
  <keyword>Knee osteoarthritis</keyword>
  <keyword>MRI</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
